Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950170-25-044078
Filing Date
2025-03-25
Accepted
2025-03-25 06:42:52
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-1/A apvo-2025-s1a_-_march_of.htm S-1/A 959630
2 EX-4.11 apvo-ex4_11.htm EX-4.11 169880
3 EX-4.12 apvo-ex4_12.htm EX-4.12 198282
4 EX-4.13 apvo-ex4_13.htm EX-4.13 210110
5 EX-5.1 apvo-ex5_1.htm EX-5.1 34972
6 EX-10.55 apvo-ex10_55.htm EX-10.55 344329
7 EX-10.56 apvo-ex10_56.htm EX-10.56 173471
8 EX-23.1 apvo-ex23_1.htm EX-23.1 3772
9 EX-FILING FEES apvo-exfiling_fees.htm EX-FILING FEES 109394
10 GRAPHIC img57496738_0.jpg GRAPHIC 12962
11 GRAPHIC img96568584_0.jpg GRAPHIC 6733
12 GRAPHIC img96568584_1.jpg GRAPHIC 199177
13 GRAPHIC img96568584_2.jpg GRAPHIC 250435
14 GRAPHIC img96568584_3.jpg GRAPHIC 14823
  Complete submission text file 0000950170-25-044078.txt   2872092
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-285476 | Film No.: 25765733
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)